Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Aytu Biopharma Inc AYTU

Healthcare Drug Manufacturers - Specialty & Generic
Aytu BioPharma, Inc., a pharmaceutical company, focuses on commercializing novel therapeutics in the United States and internationally. The company offers prescription products for the treatment of attention deficit hyperactivity disorder (ADHD), including Adzenys XR-ODT extended-release orally disintegrating tablets for patients from six years of age and above; Cotempla XR-ODT extended-release... see more

Current News (NDAQ:AYTU)

Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results

ACCESS Newswire February 3, 2026

Aytu BioPharma to Report Fiscal 2026 Second Quarter Operational and Financial Results on February 3, 2026

ACCESS Newswire January 27, 2026

Aytu BioPharma Recaps Investor Day Held on January 20, 2026

ACCESS Newswire January 20, 2026

Aytu BioPharma Highlights Opportunity for EXXUATM (gepirone) as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA

ACCESS Newswire January 20, 2026

Aytu BioPharma to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

ACCESS Newswire January 13, 2026

Aytu BioPharma Details Agenda for Investor Day Scheduled for January 20, 2026 in New York City

ACCESS Newswire January 12, 2026

Aytu BioPharma to Host Investor Day on January 20, 2026 in New York City

ACCESS Newswire December 18, 2025

Aytu BioPharma Announces Commercial Availability of EXXUA(TM) (gepirone) Extended-Release Tablets, the First and Only 5HT1a Agonist Indicated for the Treatment of Major Depressive Disorder in Adults

ACCESS Newswire December 15, 2025

Aytu BioPharma to Participate in Noble Capital Markets 21st Annual Emerging Growth Equity Conference

ACCESS Newswire November 24, 2025
View More News ››

Opinion & Analysis (NDAQ:AYTU)

Aytu Bio Shares Skyrocket After Gaining US Distribution Rights for Coronavirus Screening Test

Streetwise Reports March 11, 2020

Cerecor Shares Rise 13% on Sale of Pediatric Portfolio for $32 Million

Streetwise Reports October 16, 2019

Analyst: Acquisition by Colorado-Based Specialty Pharma 'Could Bolster Revenue 400%'

Streetwise Reports September 25, 2019

Coverage Initiated on Pharma 'Leveraging Large Markets with Differentiated Products'

Streetwise Reports December 31, 2018
View More Opinion ››

Bullboard Posts (NDAQ:AYTU)

Aytu newest presentation coming up, annual wealth event

Aytu is gonna present at the Annual Wealth Conference in Vancouver on Sep 20, the biggest event with 400+ investors and 30+ companies...
Johnthe6 - August 19, 2025

AYTU....I'm surprised that this has held up

Even after the P.O announcement On watch No position
Iseneschal - June 6, 2025

Aytu live streaming

AYTU goes live stream at the conference https://2ly.link/1yXNe
Johnthe6 - June 20, 2024

aytu new presentation

Aytu BioPharma is going to have a new presentation! It’s free! Free register here:  https://buff.ly/4bSLhjm 
Johnthe6 - June 17, 2024

Aytu biopharma presentation on Jun 20

I saw that Aytu is going to give a talk at this virtual event! And it’s free! https://buff.ly/4bSLhjm 
Johnthe6 - June 5, 2024

AYTU BIOPHARMA: LEADING THE ADHD DRUG MARKET

$AYTU Excited to share an article about Aytu BioPharma, Inc. (NASDAQ: AYTU), a pharmaceutical company focused on...
AviseAnalytics - November 28, 2023
View more Bullboard ››

Kobrea Exploration Corp.

Kobrea Exploration Corp.

Kobrea Exploration Corp. engages in the acquisition, exploration, and evaluation of mineral properties in Canada. It holds a ...
View More »

Podcasts